ArticleFrontiers in pharmacology2024

Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation.

Xiao-Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.